A new article about Bottneuro's Priority Access Program has just been published on Startupticker, Switzerland's leading platform for startup news and innovation insights.
Our very first devices are now complete and ready for the intervention phase of the MINDSTIM clinical trial with our personalized neurostimulator at t...